P/E ratio for Vertex Pharmaceuticals (VRTX)

P/E ratio history for Vertex Pharmaceuticals from 2001 to 2025

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Gilead Sciences GILD	18.4	-39.89%	🇺🇸 USA
AbbVie ABBV	166	440.31%	🇺🇸 USA
Merck MRK	12.8	-58.28%	🇺🇸 USA
Bristol-Myers Squibb BMY	17.2	-43.84%	🇺🇸 USA
Johnson & Johnson JNJ	19.6	-36.02%	🇺🇸 USA
Enanta Pharmaceuticals ENTA	-3.31	-110.79%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.